State Street Corp Veracyte, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, State Street Corp holds 3,169,700 shares of VCYT stock, worth $91.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,169,700
Previous 3,158,239
0.36%
Holding current value
$91.2 Million
Previous $93.6 Million
8.51%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding VCYT
# of Institutions
297Shares Held
77.5MCall Options Held
0Put Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA8.1MShares$233 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$224 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$151 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$109 Million0.85% of portfolio
-
Wellington Management Group LLP Boston, MA3.47MShares$99.9 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.06B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...